MAECKER; Heather

Patent Applications and Registrations

Patent applications and USPTO patent grants for MAECKER; Heather.The latest application filed is for "anti-pd-l1 antibodies, compositions and articles of manufacture".

Company Profile

3.6.20

MAECKER; Heather - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-pd-l1 Antibodies, Compositions And Articles Of Manufacture App 20210032345 - IRVING; Bryan ; et al.	2021-02-04
Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors Grant 10,646,567 - Maecker , et al.	2020-05-12
Anti-pd-l1 Antibodies, Compositions And Articles Of Manufacture App 20190016807 - IRVING; Bryan ; et al.	2019-01-17
Methods Of Treating Cancer Using Pd-l1 Axis Binding Antagonists And Vegf Antagonists App 20180236066 - MAECKER; Heather ; et al.	2018-08-23
Anti-PD-L1 antibodies, compositions and articles of manufacture Grant 9,920,123 - Irving , et al. March 20, 2	2018-03-20
Methods of treating cancer using PD-L1 axis binding antagonists and VEGF antagonists Grant 9,895,441 - Maecker , et al. February 20, 2	2018-02-20
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Mek Inhibitors App 20180021431 - MAECKER; Heather ; et al.	2018-01-25
Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors Grant 9,724,413 - Maecker , et al. August 8, 2	2017-08-08
Methods Of Using Anti-pd-l1 Antibodies And Their Use To Enhance T-cell Function To Treat Tumor Immunity App 20170107287 - IRVING; Bryan ; et al.	2017-04-20
Nucleic Acid Encoding Anti-pd-l1 Antibodies App 20160222117 - IRVING; Bryan ; et al.	2016-08-04
Anti-pd-l1 Antibodies And Articles Of Manufacture App 20150322153 - IRVING; Bryan ; et al.	2015-11-12
Methods Of Treating Cancer Using Pd-l1 Axis Binding Antagonists And Vegf Antagonists App 20150320859 - MAECKER; Heather ; et al.	2015-11-12
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Mek Inhibitors App 20140341902 - Maecker; Heather ; et al.	2014-11-20
Methods Of Using Anti-pd-l1 Antibodies And Their Use To Enhance T-cell Function To Treat Tumor Immunity App 20140065135 - Irving; Bryan ; et al.	2014-03-06
Methods Of Using Anti-pd-l1 Antibodies And Their Use To Enhance T-cell Function To Treat Tumor Immunity App 20130045201 - IRVING; BRYAN ; et al.	2013-02-21
Methods Of Using Anti-pd-l1 Antibodies And Their Use To Treat Infection Resulting From T-cell Dysfunction App 20130045200 - Irving; Bryan ; et al.	2013-02-21
Anti-pd-l1 Antibodies And Articles Of Manufacture App 20130045202 - Irving; Bryan ; et al.	2013-02-21
Methods And Compositions For Modulating Tweak And Fn14 Activity App 20120269808 - ASHKENAZI; AVI J. ; et al.	2012-10-25
Anti-PD-L1 antibodies, compositions and articles of manufacture Grant 8,217,149 - Irving , et al. July 10, 2	2012-07-10
Anti-pd-l1 Antibodies And Their Use To Enhance T-cell Function App 20100203056 - Irving; Bryan ; et al.	2010-08-12
Methods and Compositions for Modulating Tweak and Fn14 Activity App 20080286271 - Ashkenazi; Avi J. ; et al.	2008-11-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.